Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  263,357 نتائج ل ""cost""

فلترة النتائج

Format : Academic Journals فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Economic Burden of Severe Acute Malnutrition with Complications: A Cost Analysis for Inpatient Children Aged 6 to 59 Months in Northern Senegal.

  • Authors : Wassonguema B; Research Unit, Expertise & Advocacy Department, Action Contre la Faim (ACF), 93100 Montreuil, France.; ECEVE, UMR 1123, Université Paris Cité, Inserm, 75010 Paris, France.

Subjects: Severe Acute Malnutrition*/Severe Acute Malnutrition*/Severe Acute Malnutrition*/economics ; Severe Acute Malnutrition*/Severe Acute Malnutrition*/Severe Acute Malnutrition*/therapy ; Cost of Illness*

  • Source: Nutrients [Nutrients] 2024 Jul 10; Vol. 16 (14). Date of Electronic Publication: 2024 Jul 10.Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cost‑effectiveness analysis of tislelizumab plus chemotherapy in Chinese patients with advanced or metastatic oesophageal squamous cell carcinoma.

  • Authors : Zhang L; Department of Pharmacy, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.; Su H

Subjects: Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/economics ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/therapeutic use ; Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/Antibodies, Monoclonal, Humanized*/administration & dosage

  • Source: Scientific reports [Sci Rep] 2024 Jul 31; Vol. 14 (1), pp. 17734. Date of Electronic Publication: 2024 Jul 31.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

An exploratory randomised trial investigating feasibility, potential impact and cost effectiveness of link workers for people living with multimorbidity attending general practices in deprived urban communities.

  • Authors : Kiely B; Department of General Practice, Clinical Research Fellow, Royal College of Surgeons in Ireland University of Medicine and Health Sciences, 123 St Stephens Green, Dublin 2, Dublin, Ireland. .; Hobbins A

Subjects: Cost-Benefit Analysis* ; Feasibility Studies* ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: BMC primary care [BMC Prim Care] 2024 Jun 28; Vol. 25 (1), pp. 233. Date of Electronic Publication: 2024 Jun 28.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9918300889006676 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

First-line serplulimab plus chemotherapy versus chemotherapy in PD-L1-positive esophageal squamous-cell carcinoma: a cost-effectiveness analysis.

  • Authors : Liang X; Phase 1 Clinical Trial Laboratory, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China.; Meng M

Subjects: Cost-Benefit Analysis* ; B7-H1 Antigen*/B7-H1 Antigen*/B7-H1 Antigen*/metabolism ; Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/Esophageal Squamous Cell Carcinoma*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Jun 24; Vol. 14 (1), pp. 14496. Date of Electronic Publication: 2024 Jun 24.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy.

  • Authors : Wolters S; Department of Health Sciences, University of Groningen, University Medical Center Groningen, Hanzeplein 1, Groningen, 9713 GZ, The Netherlands. .; Asc Academics B.V., Hereweg 120, Groningen, 9725 AK, The Netherlands. .

Subjects: Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/economics ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/prevention & control ; Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy

  • Source: BMC neurology [BMC Neurol] 2024 Jun 24; Vol. 24 (1), pp. 214. Date of Electronic Publication: 2024 Jun 24.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Assay-guided treatment sequencing in chronic lymphocytic leukemia (CLL): a cost-effectiveness analysis.

  • Authors : Pollard S; Cancer Control Research, BC Cancer, Vancouver, Canada.; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/economics ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/genetics

  • Source: Scientific reports [Sci Rep] 2024 Jul 27; Vol. 14 (1), pp. 17294. Date of Electronic Publication: 2024 Jul 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis.

  • Authors : Yin X; Department of Management Science and Information Systems, Spears School of Business, Oklahoma State University, Tulsa, Oklahoma, United States of America.; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, United States of America.

Subjects: Gonorrhea*/Gonorrhea*/Gonorrhea*/drug therapy ; Gonorrhea*/Gonorrhea*/Gonorrhea*/epidemiology ; Gonorrhea*/Gonorrhea*/Gonorrhea*/economics

  • Source: PLoS medicine [PLoS Med] 2024 Jul 08; Vol. 21 (7), pp. e1004424. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Biomarker Driven Antifungal Stewardship (BioDriveAFS) in acute leukaemia-a multi-centre randomised controlled trial to assess clinical and cost effectiveness: a study protocol for a randomised controlled trial.

  • Authors : Flett L; Department of Health Sciences, University of York, York, UK. .; Abdelatif R

Subjects: Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/therapeutic use ; Antifungal Agents*/Antifungal Agents*/Antifungal Agents*/economics ; Cost-Benefit Analysis*

  • Source: Trials [Trials] 2024 Jun 28; Vol. 25 (1), pp. 427. Date of Electronic Publication: 2024 Jun 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The cost effectiveness of early assessment and intervention by a dedicated health and social care professional team for older adults in the emergency department compared to treatment-as-usual: Economic evaluation of the OPTI-MEND trial.

  • Authors : Trépel D; Trinity College Dublin, Dublin, Ireland.; Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Subjects: Cost-Benefit Analysis* ; Emergency Service, Hospital*/Emergency Service, Hospital*/Emergency Service, Hospital*/economics; Humans

  • Source: PloS one [PLoS One] 2024 Jun 25; Vol. 19 (6), pp. e0298162. Date of Electronic Publication: 2024 Jun 25 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cost-effectiveness analysis of granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced febrile neutropenia in patients with breast cancer in Taiwan.

  • Authors : Tseng TH; Department of Clinical Pharmacy, School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan.; Chiang SC

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Cost-Benefit Analysis* ; Granulocyte Colony-Stimulating Factor*/Granulocyte Colony-Stimulating Factor*/Granulocyte Colony-Stimulating Factor*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Jun 10; Vol. 19 (6), pp. e0303294. Date of Electronic Publication: 2024 Jun 10 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  263,357 نتائج ل ""cost""